Simone is Vice President and Editor in Chief at BioCentury, overseeing analysis, research, and data across its intelligence platform. She moderates global panels on key biopharma topics and has interviewed industry leaders, including CEOs, top VCs, regulators, and academic pioneers. She also directs BioCentury conference content, co-hosts The BioCentury Show, and is a regular on the BioCentury This Week podcast.
Her expertise spans biomedical innovation, translational breakthroughs, and their impact on the biotech ecosystem. She and her team analyze investment trends, policy, and industry dynamics, positioning BioCentury as a top source for decision-makers.
A trained bench scientist and translational researcher, Simone joined BioCentury in 2013, led its flagship publication from 2018, and became VP & Editor in Chief in 2019. She previously ran a research lab at Nektar Therapeutics, worked as a consultant at Exponent Inc., and was an independent researcher at the Weizmann Institute. She has advised Stanford’s SPARK Translational Program and UCSF’s CTSI Catalyst Program. A Fulbright scholar, she earned her Ph.D. from the Weizmann Institute and M.A./B.A. from Cambridge University in Pharmacology.